Rubric Capital Management LP Tarsus Pharmaceuticals, Inc. Transaction History

Rubric Capital Management LP

  • $3.59 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$11.92 - $16.27 $753,868 - $1.03 Million
-63,244 Reduced 22.21%
221,488 $2.78 Million
Q3 2022

Nov 14, 2022
BUY
$14.08 - $18.5 $1.16 Million - $1.52 Million
82,084 Added 40.51%
284,732 $4.88 Million
Q2 2022

Aug 15, 2022
BUY
$11.08 - $19.08 $2.25 Million - $3.87 Million
202,648 New
202,648 $2.96 Million

Others Institutions Holding TARS

# of Institutions
173
Shares Held
43.6M
Call Options Held
484K
Put Options Held
4.1K
View Full List

About Tarsus Pharmaceuticals, Inc.

TARS Quotes by TradingView
  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.31B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email